These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18220701)

  • 1. Leukocyte influx in atherosclerosis.
    Galkina E; Ley K
    Curr Drug Targets; 2007 Dec; 8(12):1239-48. PubMed ID: 18220701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte migration into atherosclerotic plaque.
    Li J; Ley K
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):40-9. PubMed ID: 25301842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall.
    Galkina E; Harry BL; Ludwig A; Liehn EA; Sanders JM; Bruce A; Weber C; Ley K
    Circulation; 2007 Oct; 116(16):1801-11. PubMed ID: 17909108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR6 regulates the recruitment of pro-inflammatory IL-17A-producing T cells into atherosclerotic aortas.
    Butcher MJ; Wu CI; Waseem T; Galkina EV
    Int Immunol; 2016 May; 28(5):255-61. PubMed ID: 26614640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas.
    Zernecke A; Winkels H; Cochain C; Williams JW; Wolf D; Soehnlein O; Robbins CS; Monaco C; Park I; McNamara CA; Binder CJ; Cybulsky MI; Scipione CA; Hedrick CC; Galkina EV; Kyaw T; Ghosheh Y; Dinh HQ; Ley K
    Circ Res; 2020 Jul; 127(3):402-426. PubMed ID: 32673538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent.
    Galkina E; Kadl A; Sanders J; Varughese D; Sarembock IJ; Ley K
    J Exp Med; 2006 May; 203(5):1273-82. PubMed ID: 16682495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of leukocyte recruitment to atherosclerotic lesions: future prospects.
    Eriksson EE
    Curr Opin Lipidol; 2004 Oct; 15(5):553-8. PubMed ID: 15361791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokines in atherosclerosis: an update.
    Zernecke A; Shagdarsuren E; Weber C
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1897-908. PubMed ID: 18566299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice.
    Grandoch M; Feldmann K; Göthert JR; Dick LS; Homann S; Klatt C; Bayer JK; Waldheim JN; Rabausch B; Nagy N; Oberhuber A; Deenen R; Köhrer K; Lehr S; Homey B; Pfeffer K; Fischer JW
    Circ Res; 2015 Apr; 116(8):e57-68. PubMed ID: 25740843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression.
    Wezel A; Lagraauw HM; van der Velden D; de Jager SC; Quax PH; Kuiper J; Bot I
    Atherosclerosis; 2015 Aug; 241(2):289-96. PubMed ID: 26062988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis as an inflammatory disease.
    Tuttolomondo A; Di Raimondo D; Pecoraro R; Arnao V; Pinto A; Licata G
    Curr Pharm Des; 2012; 18(28):4266-88. PubMed ID: 22390643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines in the vascular inflammatory response of atherosclerosis.
    Zernecke A; Weber C
    Cardiovasc Res; 2010 May; 86(2):192-201. PubMed ID: 20007309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
    Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
    Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological inhibition of the chemokine receptor, CX3CR1, reduces atherosclerosis in mice.
    Poupel L; Boissonnas A; Hermand P; Dorgham K; Guyon E; Auvynet C; Charles FS; Lesnik P; Deterre P; Combadiere C
    Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2297-305. PubMed ID: 23887641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemokine binding protein 'M3' limits atherosclerosis in apolipoprotein E-/- mice.
    Ravindran D; Ridiandries A; Vanags LZ; Henriquez R; Cartland S; Tan JT; Bursill CA
    PLoS One; 2017; 12(3):e0173224. PubMed ID: 28282403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometry analysis of immune cells within murine aortas.
    Butcher MJ; Herre M; Ley K; Galkina E
    J Vis Exp; 2011 Jul; (53):. PubMed ID: 21750492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta.
    Butcher MJ; Waseem TC; Galkina EV
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1496-506. PubMed ID: 27365405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokines: inflammatory mediators of atherosclerosis.
    Liehn EA; Zernecke A; Postea O; Weber C
    Arch Physiol Biochem; 2006; 112(4-5):229-38. PubMed ID: 17178596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of Four-and-a-Half LIM Domain Protein 2 Decreases Atherosclerosis in ApoE-/- Mice.
    Ebrahimian T; Simon D; Lemarié CA; Simeone S; Heidari M; Mann KK; Wassmann S; Lehoux S
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1190-7. PubMed ID: 25767273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice.
    Koenen RR; von Hundelshausen P; Nesmelova IV; Zernecke A; Liehn EA; Sarabi A; Kramp BK; Piccinini AM; Paludan SR; Kowalska MA; Kungl AJ; Hackeng TM; Mayo KH; Weber C
    Nat Med; 2009 Jan; 15(1):97-103. PubMed ID: 19122657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.